{
    "SPADE_UN_26172": {
        "Sequence Information": {
            "Peptide Name": "",
            "Sequence": "WRFRWRW",
            "Sequence Length": 7,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells",
                    "Pubmed ID": "14959890",
                    "Reference": "J Pept Sci. 2004;10:37-46",
                    "Author": "Yang N, Strøm MB, Mekonnen SM, Svendsen JS, Rekdal O",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/14959890"
                }
            ],
            "Mass": 1192.38,
            "PI": 12.0,
            "Net Charge": 3,
            "Hydrophobicity": -1.91,
            "Frequent Amino Acids": "RWF",
            "Absent Amino Acids": "ACDEGHIKLMNOPQSTUVY",
            "Basic Residues": 3,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 1,
            "Polar Residues": 6,
            "Positive Residues": 3,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_26172",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02338",
                    "Similarity": 1.0,
                    "Sequence": "GTQRCWNLYGKCRHRCSKKERVYVYCVNNKMCCVKPKYQPKERWWRF"
                },
                {
                    "SPADE_ID": "SPADE_N_08805",
                    "Similarity": 1.0,
                    "Sequence": "FIRWRFRWWRWRR"
                },
                {
                    "SPADE_ID": "SPADE_N_13177",
                    "Similarity": 1.0,
                    "Sequence": "AARIILRWRFR"
                }
            ],
            "Hemolytic Activity": "Human fibroblasts MRC-5:IC50=592 µM,Human erythrocytes:50% Hemolysis=765 µM",
            "Target Organism": "Murine fibrosarcoma MethA(IC50=215µM),Human mammary carcinoma MT-1(IC50=327µM),Human lung carcinoma A549(IC50=338µM),Escherichia coli ATCC 25922(MIC=4.2µM),Staphylococcus aureus ATCC 25923(MIC=<2.1µM)"
        }
    }
}